21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
72.19.Z - Scientific research and development activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,8 | 7,9 | 7,6 | -3,8 |
EBITDA | 7,8 | 10,2 | 10,9 | 7,2 |
Short time liabilities | 16,9 | 22 | 27,4 | 24,9 |
Equity capital | 21 | 22,9 | 22,5 | -1,7 |
Operating profit (EBIT) | 6,4 | 8,8 | 9,3 | 6 |
Assets | 50,9 | 60,1 | 69,2 | 15,1 |
Net profit (loss) | 4,6 | 6,5 | 6,1 | -6 |
Cash | 0,1 | 0,1 | 0,5 | 653,5 |
Net income from sale | 59,4 | 61,1 | 76,8 | 25,7 |
Liabilities and provisions for liabilities | 29,9 | 37,2 | 46,7 | 25,5 |
Working assets | 26,7 | 30,2 | 35,1 | 16,5 |
Depreciation | 1,3 | 1,4 | 1,6 | 14,6 |
% | % | % | p.p. | |
Profitability of capital | 21,8 | 28,4 | 27,2 | -1,2 |
Equity capital to total assets | 41,2 | 38,1 | 32,5 | -5,6 |
Gross profit margin | 9,8 | 12,9 | 9,9 | -3 |
EBITDA Margin | 13,1 | 16,6 | 14,2 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 104 | 131 | 130 | -1 |
Current financial liquidity indicator | 1.412456750869751 | 1.250034213066101 | 1.1770046949386597 | -0,1 |
Net dept to EBITDA | 2.1602983474731445 | 1.8335336446762085 | 2.2122676372528076 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane